Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The preparation of 'monoprecipitin' antisera to herpes virus specific antigens.

× No keyword cloud information.

17 in total

1. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.

Authors: G R Skinner; C Fink; J Melling; C Wiblin; B Thornton; J Hallworth; W Gardner; P McLeish; C Hartley; A Buchan
Journal: Med Microbiol Immunol Date: 1992 Impact factor: 3.402

2. Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection.

Authors: G R Skinner; D R Williams; A Buchan; J Whitney; M Harding; K Bodfish
Journal: Med Microbiol Immunol Date: 1978-11-17 Impact factor: 3.402

3. Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors: M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal: Arch Virol Date: 1975 Impact factor: 2.574

4. Immunization against multiple viruses by using solid-matrix-antibody-antigen complexes.

Authors: R E Randall; D F Young
Journal: J Virol Date: 1989-04 Impact factor: 5.103

5. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.

Authors: M F Para; M L Parish; A G Noble; P G Spear
Journal: J Virol Date: 1985-08 Impact factor: 5.103

6. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.

Authors: G H Cohen; M Ponce de Leon; C Nichols
Journal: J Virol Date: 1972-11 Impact factor: 5.103

7. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

Authors: C Grose; D P Edwards; W E Friedrichs; K A Weigle; W L McGuire
Journal: Infect Immun Date: 1983-04 Impact factor: 3.441

8. The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors: G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal: Med Microbiol Immunol Date: 1980 Impact factor: 3.402

9. [Structure and function of virus-induced antigens in cultured cells infected with Merek's disease and turkey herpes viruses. II. Isolation of intracellular antigens from infected cells (author's transl)].

Authors: O R Kaaden
Journal: Med Microbiol Immunol Date: 1977-10-07 Impact factor: 3.402

10. Crossed immunoelectrophoretic studies of the solubility immunogenicity of herpes simplex virus antigens.

Authors: B F Vestergaard; O J Bjerrum; B Norrild; P C Grauballe
Journal: J Virol Date: 1977-10 Impact factor: 5.103